Literature DB >> 6401506

Clinical aspects of delta infection.

T Moestrup, B G Hansson, A Widell, E Nordenfelt.   

Abstract

The clinical features of delta infection were analysed retrospectively in 191 hepatitis B surface antigen (HBsAg) carriers and 592 cases of acute hepatitis B seen over 11 years in the Swedish town of Malmö (population 250 000). With a few exceptions delta infections occurred exclusively in drug addicts. In the chronic HBsAg-carriers the most common clinical manifestation was an episode of acute hepatitis, which in some individuals became severe with a pronounced rise in serum alanine aminotransferase activity for many months. During the period of delta infection the HBsAg titre was lowered and in three out of 26 cases the patient lost HBsAg altogether and developed hepatitis B surface antibodies (anti-HBs). In one patient the acute hepatitis due to delta infection was fulminant and fatal. In patients with acute hepatitis B the clinical picture did not distinguish between those with and without simultaneous delta infection. The frequency with which acute hepatitis B was succeeded by a chronic carrier state was the same whether or not the patient was infected simultaneously with the delta agent. The discovery of the delta agent has improved understanding of the natural history of chronic hepatitis B infection in drug addicts. Thus, instances of acute hepatitis in a chronic carrier, previously termed hepatitis non-A, non-B, may actually be episodes of delta infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401506      PMCID: PMC1546393          DOI: 10.1136/bmj.286.6359.87

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

2.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

3.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  Infection with the delta agent in chronic HBsAg carriers.

Authors:  A Smedile; P Dentico; A Zanetti; E Sagnelli; E Nordenfelt; G C Actis; M Rizzetto
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

5.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

6.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

  6 in total
  26 in total

1.  Acute hepatitis B and hepatitis D co-infection in the Stockholm region in the 1970s and 1980s--a comparison.

Authors:  G Lindh; L Mattsson; M von Sydow; O Weiland
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Phylogenetic analysis of hepatitis D viruses indicating a new genotype I subgroup among African isolates.

Authors:  Y Y Zhang; E Tsega; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

3.  Epidemiological aspects of viral hepatitis B and delta-hepatitis in selected population from Białystok District, Poland.

Authors:  P Borón; A Borón-Kaczmarska; E Bobrowska; H Kamińska; W Lapiński
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

4.  Delta infection in eastern Sicily.

Authors:  A Smedile; M A Freni; L Caruso; A Ajello; C Trischitta; M L Resta; G Bertino; G Berlinghieri; S Rapisarda; L Di Geronimo
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

Review 5.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

6.  Hepatitis delta infections.

Authors:  K G Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

7.  Epidemiology of hepatitis delta virus (HDV) infection.

Authors:  A Ponzetto; B Forzani; P P Parravicini; C Hele; A Zanetti; M Rizzetto
Journal:  Eur J Epidemiol       Date:  1985-12       Impact factor: 8.082

Review 8.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

9.  Delta infection among patients with chronic hepatitis B in the Stockholm region.

Authors:  G Lindh; O Weiland; B G Hansson; A Svedmyr
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

10.  Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

Authors:  K P Chin; S Govindarajan; A G Redeker
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.